Literature DB >> 30713401

Inhibitory Effect of Photodynamic Therapy with Indocyanine Green on Rat Smooth Muscle Cells.

Jih-Shyong Lin1,2, Chia-Jung Wang2, Wen-Tyng Li2,3.   

Abstract

BACKGROUND: Vascular smooth muscle cells play a critical role in the intimal hyperplasia of restenosis. A previous study of a rat balloon injury model demonstrated that photodynamic therapy (PDT) using indocyanine green (ICG) and near-infrared (NIR) light irradiation reduced intimal hyperplasia in carotid arteries. However, the effect of ICG-PDT on smooth muscle cells remains unclear. This study aimed to evaluate the effects of PDT with ICG and NIR irradiation on the viability of vascular smooth muscle (A-10) cells.
METHODS: A-10 cells were incubated with ICG at different concentrations for different time intervals. Intracellular accumulation of ICG inside the cells was observed by light microscopy, ultraviolet-visible (UV-VIS) spectrophotometry and spectrofluorometry. Cell viability and cell death after ICG-PDT were assessed by 3-(4,5-dimethylthiazol-2-yl)- 2,5-diphenyltetrazolium bromide assay and lactate dehydrogenase release assay. Changes in nuclear morphology and cell cycle distribution were evaluated to determine the possible cell death mechanism mediated by ICG-PDT.
RESULTS: ICG uptake in A-10 cells increased with the amount of ICG in the culture media. The intracellular accumulation of ICG reached a maximum at 8 h. After ICG-PDT, cell viability decreased and cell death increased in a concentration- dependent manner. The half maximal inhibitory concentration of ICG was 8.3 μM with 4 J/cm2 NIR irradiation. Membrane blebbing and chromatin condensation were observed, and the percentage of cells in the sub-G1 phase increased after ICG-PDT. Thus, apoptosis might be responsible for decreasing the viability of A-10 cells by ICG-PDT.
CONCLUSIONS: This study demonstrated that ICG-PDT had an inhibitory effect on smooth muscle cells, possibly via an apoptosis pathway.

Entities:  

Keywords:  Cell viability; Indocyanine green; Near-infrared; Photodynamic therapy; Smooth muscle cell

Year:  2019        PMID: 30713401      PMCID: PMC6342837          DOI: 10.6515/ACS.201901_35(1).20180731A

Source DB:  PubMed          Journal:  Acta Cardiol Sin        ISSN: 1011-6842            Impact factor:   2.672


  49 in total

1.  Photodynamic therapy generates a matrix barrier to invasive vascular cell migration.

Authors:  M Overhaus; J Heckenkamp; S Kossodo; D Leszczynski; G M LaMuraglia
Journal:  Circ Res       Date:  2000-02-18       Impact factor: 17.367

2.  Mechanisms of reduced human vascular cell migration after photodynamic therapy.

Authors:  Peter R Waterman; Marcus Overhaus; Joerg Heckenkamp; Giuseppe R Nigri; Patrick F C Fungaloi; Michael E Landis; Sylvie C Kossodo; Glenn M LaMuraglia
Journal:  Photochem Photobiol       Date:  2002-01       Impact factor: 3.421

Review 3.  Inflammation and restenosis in the stent era.

Authors:  Frederick G P Welt; Campbell Rogers
Journal:  Arterioscler Thromb Vasc Biol       Date:  2002-11-01       Impact factor: 8.311

4.  Photodynamic therapy with motexafin lutetium (Lu-Tex) reduces experimental graft coronary artery disease.

Authors:  A Yamaguchi; K W Woodburn; M Hayase; G Hoyt; R C Robbins
Journal:  Transplantation       Date:  2001-06-15       Impact factor: 4.939

Review 5.  Regulation of smooth muscle phenotype.

Authors:  Ichiro Manabe; Ryozo Nagai
Journal:  Curr Atheroscler Rep       Date:  2003-05       Impact factor: 5.113

6.  Photodynamic therapy of atherosclerosis using YAG-OPO laser and Porfimer sodium, and comparison with using argon-dye laser.

Authors:  T Amemiya; H Nakajima; T Katoh; H Rakue; M Miyagi; C Ibukiyama
Journal:  Jpn Circ J       Date:  1999-04

7.  Photodynamic therapy for the prevention of intimal hyperplasia in balloon-injured rabbit arteries.

Authors:  M Usui; T Asahara; Y Naitoh; T Katoh; C Ibukiyama
Journal:  Jpn Circ J       Date:  1999-05

8.  Enzymatically degraded, nonoxidized LDL induces human vascular smooth muscle cell activation, foam cell transformation, and proliferation.

Authors:  M Klouche; S Rose-John; W Schmiedt; S Bhakdi
Journal:  Circulation       Date:  2000-04-18       Impact factor: 29.690

Review 9.  Progression of atheroma: a struggle between death and procreation.

Authors:  Yong-Jian Geng; Peter Libby
Journal:  Arterioscler Thromb Vasc Biol       Date:  2002-09-01       Impact factor: 8.311

10.  Phase I drug and light dose-escalation trial of motexafin lutetium and far red light activation (phototherapy) in subjects with coronary artery disease undergoing percutaneous coronary intervention and stent deployment: procedural and long-term results.

Authors:  Dean J Kereiakes; Arthur M Szyniszewski; Dennis Wahr; Howard C Herrmann; Daniel I Simon; Campbell Rogers; Paul Kramer; Wendy Shear; Alan C Yeung; Kendrick A Shunk; Tony M Chou; Jeffrey Popma; Peter Fitzgerald; Tanya E Carroll; David Forer; Daniel C Adelman
Journal:  Circulation       Date:  2003-08-25       Impact factor: 29.690

View more
  3 in total

1.  Plasma flow distal to tourniquet placement provides a physiological mechanism for tissue salvage.

Authors:  Emily Busse; Cheryl Hickey; Nicole Vasilakos; Kennon Stewart; Fred O'Brien; Jessica Rivera; Luis Marrero; Michelle Lacey; Rebecca Schroll; Keith Van Meter; Mimi C Sammarco
Journal:  PLoS One       Date:  2020-12-21       Impact factor: 3.752

2.  Serum Endocan Levels Predict Drug-Eluting Stent Restenosis in Patients with Stable Angina Pectoris.

Authors:  Ayhan Küp; Cüneyt Toprak; Emrah Bayam; Servet İzcı; Abdulkadir Uslu; Mehmet Çelık; İsmail Balaban; Sinan Cerşıt; Süleyman Barutçu; Pınar Demir Gündoğmuş
Journal:  Acta Cardiol Sin       Date:  2020-03       Impact factor: 2.672

3.  Inhibition of Notch Signaling Alleviated Diabetic Macrovasculopathy in an In Vitro Model.

Authors:  Kuo-Li Pan; Yung-Chien Hsu; Chun-Wu Tung; Shih-Tai Chang; Chang-Min Chung; Chun-Liang Lin
Journal:  Acta Cardiol Sin       Date:  2020-09       Impact factor: 2.672

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.